Answers are grounded in this paper and cite their sources.
This paper develops a validation framework for governed AI execution agents in digital-asset markets. It separates development-program evidence from launch-candidate evidence; compares governed and ungated AI policies under common baselines; tests signal calibration after costs; applies walk-forward and overfitting controls; evaluates component ablations; and reviews stress-event, venue-execution, and supervisor-intervention records.The framework is applied to a cleared anonymized validation data room. The scientific interpretation is not that future returns are guaranteed, but that risk projection, regime gating, venue-health control, and supervisor escalation can be tested as stabilizing mechanisms. External investment-performance claims require independent reconciliation to source order, account, custody, fee, and funding records.
No takes yet. Share an insight, caveat, or question.
Montrix AI Research Program (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: